Leadership Transition at Carl Zeiss Meditec AG

Carl Zeiss Meditec AG announces a change in leadership as Dr. Markus Weber steps down as President and CEO, effective on May 31, 2025. Dr. Weber's departure was made upon mutual agreement with the Supervisory Board. His successor, Maximilian Foerst, will assume the role starting June 1, 2025. Foerst brings extensive experience as the current Head of ZEISS Greater China, where he oversees significant business operations generating around two billion euros annually.

Under Dr. Weber’s leadership, Carl Zeiss Meditec AG strengthened its position in the ophthalmology and microsurgery markets, notably through the acquisition of Dutch Ophthalmic Research Center (D.O.R.C.).

Maximilian Foerst expresses optimism about leveraging megatrends like demographic change and digitalization to drive the company forward. Andreas Pecher, Chairman of the Supervisory Board, highlights Foerst's competence and international experience as assets for future growth.